Nasopharyngeal cancer: a promising future-Reference-Cited by-同舟云学术

Nasopharyngeal cancer: a promising future

Published:2012-02 Issue:2 Volume:13 Page:116-118
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Wee Joseph

Publisher

Elsevier BV

Subject

Oncology

Reference15 articles.

1. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099;Al-Sarraf;J Clin Oncol,1998

2. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience;Lee;Int J Radiat Oncol Biol Phys,2002

3. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial;Chen;Lancet Oncol,2011

4. Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study;Kwong;J Clin Oncol,2004

5. The role of adjuvant chemotherapy after concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma;Lee;Int J Radiat Oncol Biol Phys,2007

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of neo-adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma;IP Indian Journal of Anatomy and Surgery of Head, Neck and Brain;2022-07-15

2. Long-term efficacy and adverse reactions of IMRT combined with Endostar versus IMRT combined with chemotherapy for locally advanced nasopharyngeal carcinoma: a retrospective study;Annals of Palliative Medicine;2021-11

3. The prognostic value of before treatment neutrophil-to-lymphocyte ratio in nasopharyngeal carcinoma;European Archives of Oto-Rhino-Laryngology;2021-09-12

4. Comparison of the efficacy between concurrent chemoradiotherapy with or without adjuvant chemotherapy for stage II nasopharyngeal carcinoma;Medicine;2020-07-17

5. Influence of concurrent chemotherapy on locoregionally advanced nasopharyngeal carcinoma treated with neoadjuvant chemotherapy plus intensity-modulated radiotherapy: A retrospective matched analysis;Scientific Reports;2020-02-12